Document is current
Any future updates will be listed below
-
Authors
Dumelie, Jason G. https://orcid.org/0000-0002-6926-4843
Chen, Qiuying
Miller, Dawson
Attarwala, Nabeel https://orcid.org/0000-0003-2112-9754
Gross, Steven S.
Jaffrey, Samie R. https://orcid.org/0000-0003-3615-6958
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA186702, R01AR076029, R21ES032347, R21NS118633, P01 HD067244)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R35NS111631)
- License Information
-
More Information
Article History
Received: 24 May 2022
Accepted: 8 October 2023
First Online: 16 November 2023
Competing interests
: S.R.J. is scientific advisor to, and owns equity in, 858 Therapeutics. The remaining authors declare no competing interests.
